Biologic and Biosimilars


Innovative biologics and upcoming introduction & availability of biosililars developing by recent research and evolution. Various draughts and ultimate guidance has disclosed by FDA to serve bio similar sponsors in expansion data to encourage bio similar submission. FDA rules and regulation are implemented for biosimilars


  • Disease modified ant rheumatic drugs
  • Nonbiologic and conventional
  • Vast produced in living being

Related Conference of Biologic and Biosimilars

July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Biologic and Biosimilars Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in